Evaluate Safety and Efficacy of Rifamycin SV MMX in the Treatment of Traveler's Diarrhea in Children Age 6 to 11 Years

NCT04026984 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

142

Enrollment

INDUSTRY

Sponsor class

Conditions

Traveler's Diarrhea

Interventions

DRUG: Rifamycin SV-MMX
DRUG: Placebo

Sponsor

RedHill Biopharma Limited